Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04049097
Recruitment Status : Enrolling by invitation
First Posted : August 7, 2019
Last Update Posted : November 12, 2020
Sponsor:
Collaborators:
University of Kansas Medical Center
University College, London
Information provided by (Responsible Party):
Orphazyme

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : May 22, 2022
Estimated Study Completion Date : May 22, 2022